TickerKhojPharmaceuticals · Pharmaceuticals: Major · NSE: SUNLOC · data 2026-11-02
Sunil Healthcare Ltd.
In plain words
Price: 17.1% below its 52-week high of ₹82.
Delivery: 85.9% of traded shares were kept for delivery over the last 10 sessions, against 85.7% over the last 49.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹84 cr |
| Net profit (last 12 months) | ₹4 cr |
| Sales growth, 3 years (yearly) | -7.5% |
| Profit growth, 3 years (yearly) | -15.7% |
At a glance
P/E 19.6, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 5.9%, ROCE 6.0%, operating margin 7.4%: how much profit it earns on the money it uses.
Debt/equity 0.80, Profit growth -15.7% and sales growth -7.5% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (5.9%).
- Profit fell 15.7% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
9/100 · Weak over the last ~60 sessions, data 2026-11-02
- Delivery vs usual 4/30: Delivery 54.1% over the last 20 sessions vs 86.4% in the 40 before (0.63x); shares delivered per day 0.3x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Sunil Healthcare Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.8.
What is Sunil Healthcare Ltd.'s P/E ratio?
About 19.6, based on the last 12 months' earnings and a price of ₹67.99 (data 2026-11-02).
What is the 52-week high and low of Sunil Healthcare Ltd.?
The 52-week high is ₹82 and the 52-week low is ₹60.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Sunil Healthcare Ltd. | ₹67.99 | ₹70 cr | 19.6 | — | 5.9% | 6% | 0.8 | -4.2% |
| Vaishali Pharma Ltd. | ₹6.55 | ₹87 cr | 20 | — | 6.2% | 3.6% | 0.27 | -36.1% |
| Vilin Bio Med Ltd. | ₹49.5 | ₹73 cr | 38.9 | 2.7 | 7.5% | 11.3% | 0.01 | +87.1% |
| Onyx Biotec Ltd. | ₹36 | ₹65 cr | — | — | -0.4% | 0.5% | 0.27 | -12.4% |
| Zenith Drugs Ltd. | ₹37 | ₹63 cr | 16.1 | 0.9 | 5.5% | 9.3% | 0.75 | -40.5% |
| Vivimed Labs Limited | ₹5.51 | ₹51 cr | — | — | — | -43.6% | — | +5.0% |
Compare SUNLOC with VAISHALI in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SUNLOC in TickerKhoj →